Dr. Madhuri (Mani) Roy focuses her practice in developing and implementing comprehensive patent portfolio strategies for biotechnology, pharmaceutical and chemical companies. This work includes patent preparation and prosecution, strategic patent counseling and intellectual property due diligence. She also has carried out investor-side and company-side due diligences, freedom-to-operate analyses, patentability analyses and pre-litigation work involving questions of validity and non-infringement.

Download full bio 


  • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 

  • DICE Therapeutics – $234.6 Million IPO 

  • Erasca – $345 Million IPO 

  • Graphite Bio – $274 Million IPO 

  • Day One Biopharmaceuticals – $184 Million IPO 

  • View all


  • Santa Clara University School of Law
    JD, magna cum laude, 2013

  • Stanford University
    PhD, MS, Neurobiology

  • Cornell University
    BA, Biology

Admissions & Credentials


U.S. Patent and Trademark Office


  • American Bar Association

  • South Asian Bar Association

Rankings & Accolades

    Best Lawyers "Ones to Watch" - Intellectual Property